The clinical status of Tpot as a predictor? or why no tempest in the Tpot!
- 1 July 1995
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 32 (5) , 1539-1541
- https://doi.org/10.1016/0360-3016(95)00261-v
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Present Status of EORTC Trials of Hyperfractionated and Accelerated Radiotherapy on Head and Neck CarcinomaPublished by Springer Nature ,1994
- Potential doubling time in head and neck tumors treated by primary radiotherapy: Preliminary evidence for a prognostic significance in local controlInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Critical appraisal of in situ cell kinetic measurements as response predictors in human tumorsSeminars in Radiation Oncology, 1993
- Determining Tpot in heterogeneous systems: A new approach illustrated with multicell spheroidsCytometry, 1993
- Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neckBritish Journal of Cancer, 1992
- Predictive value of potential doubling time for radiotherapy of head and neck tumor patients: Results from the EORTC cooperative trial 22851Seminars in Radiation Oncology, 1992
- Unconventional fractionation studies and Tpot correlationSeminars in Radiation Oncology, 1992
- Status of the experience of the EORTC cooperative group of radiotherapy with hyperfractionated and accelerated radiotherapy regimesSeminars in Radiation Oncology, 1992
- Cell kinetic analysis of mixed populations using three‐color fluorescence flow cytometryCytometry, 1991
- The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: An interim reportInternational Journal of Radiation Oncology*Biology*Physics, 1990